Acumen Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $290 |
Gross Profit | -45 | -44 | 251 |
EBITDA | -19,488 | -13,829 | -13,471 |
EBIT | -19,533 | -13,873 | -13,510 |
Net Income | -20,537 | -14,873 | -16,497 |
Net Change In Cash | 0 | 0 | 290 |
Free Cash Flow | -16,550 | -17,870 | -8,328 |
Cash | 67,955 | 46,930 | 66,886 |
Basic Shares | 60,079 | 59,812 | 57,910 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,436 | $1,436 |
Gross Profit | -42,318 | -169 | -4 | 1,428 |
EBITDA | -51,606 | -42,687 | 61,577 | 587 |
EBIT | -51,790 | -42,856 | 61,573 | -7,325 |
Net Income | -52,371 | -40,475 | -181,679 | -7,324 |
Net Change In Cash | 0 | 0 | 1,436 | 1,436 |
Cost of Revenue | 7,939 | 78,385 | ||
Free Cash Flow | -43,085 | -35,314 | -18,001 | -7,450 |
Cash | 66,886 | 130,101 | 122,162 | 43,777 |
Basic Shares | 48,609 | 40,601 | 40,473 | 40,151 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.49 |
2024-06-30 | -$0.34 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.28 |
